Evaluation of brilliance ESBL agar, a novel chromogenic medium for detection of extended-spectrum-beta-lactamase-producing Enterobacteriaceae

Journal of Clinical Microbiology

Volumn 48, Issue 6, 2010, Pages 2091-2096

  Huang, Te Din ^a,b   Bogaerts, Pierre ^b   Berhin, Catherine ^b   Guisset, Amelie ^b   Glupczynski, Youri ^a,b  

^a CLINIQUES UNIVERSITAIRES SAINT LUC   (Belgium)

^b UNIVERSITY HOSPITAL OF MONT GODINNE   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

CEFTAZIDIME; CHROMOGENIC SUBSTRATE; EXTENDED SPECTRUM BETA LACTAMASE;

AGAR MEDIUM; ARTICLE; BACTERIAL GROWTH; BACTERIUM DETECTION; BACTERIUM ISOLATE; BACTERIUM ISOLATION; COMPETITIVE INHIBITION; CONTROLLED STUDY; ENTEROBACTER AEROGENES; ENTEROBACTER CLOACAE; ENTEROBACTERIACEAE; HUMAN; KLEBSIELLA OXYTOCA; KLEBSIELLA PNEUMONIAE; NONHUMAN; PRIORITY JOURNAL; PSEUDOMONAS; SCREENING;

AGAR; BACTERIOLOGICAL TECHNIQUES; BETA-LACTAMASES; CULTURE MEDIA; ENTEROBACTERIACEAE; ENTEROBACTERIACEAE INFECTIONS; HUMANS; MASS SCREENING; PREDICTIVE VALUE OF TESTS; SENSITIVITY AND SPECIFICITY;

ENTEROBACTERIACEAE; NEGIBACTERIA;

EID: 77952930310     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/JCM.02342-09     Document Type: Article

References (18)

1. Brun-Buisson, C., P. Legrand, A. Philippon, F. Montravers, M. Ansquer, and J. Duval. 1987. Transferable enzymatic resistance to third-generation cephalosporins during nosocomial outbreak of multiresistant Klebsiella pneumoniae. Lancet 2:302-306. (Pubitemid 17104206)
2. Cantón, R., and T. M. Coque. 2006. The CTX-M beta-lactamase pandemic. Curr. Opin. Microbiol. 9:466-475.
3. Clinical and Laboratory Standards Institute. 2009. Performance standards for antimicrobial susceptibility testing; 17th informational supplement. M100-S17. Clinical and Laboratory Standards Institute, Wayne, PA.
4. De Gheldre, Y., V. Avesani, C. Berhin, M. Delmee, and Y. Glupczynski. 2003. Evaluation of Oxoid combination discs for detection of extended-spectrum beta-lactamases. J. Antimicrob. Chemother. 52:591-597.
5. Diederen, B. M., M. L. van Leest, I. van Duijn, P. Willemse, P. H. van Keulen, and J. A. Kluytmans. 2006. Performance of MRSA ID, a new chromogenic medium for detection of methicillin-resistant Staphylococcus aureus. J. Clin. Microbiol. 44:586-588.
6. Drieux, L., F. Brossier, W. Sougakoff, and V. Jarlier. 2008. Phenotypic detection of extended-spectrum beta-lactamase production in Enterobacteriaceae: review and bench guide. Clin. Microbiol. Infect. 14(Suppl. 1):90-103.
7. Färber, J., K. A. Moder, F. Layer, I. Tammer, W. Konig, and B. Konig. 2008. Extended-spectrum beta-lactamase detection with different panels for automated susceptibility testing and with a chromogenic medium. J. Clin. Microbiol. 46:3721-3727.
8. Glupczynski, Y., C. Berhin, C. Bauraing, and P. Bogaerts. 2007. Evaluation of a new selective chromogenic agar medium for detection of extended-spectrum beta-lactamase-producing Enterobacteriaceae. J. Clin. Microbiol. 45:501-505.
9. Ledeboer, N. A., K. Das, M. Eveland, C. Roger-Dalbert, S. Mailler, S. Chatellier, and W. M. Dunne. 2007. Evaluation of a novel chromogenic agar medium for isolation and differentiation of vancomycin-resistant Enterococcus faecium and Enterococcus faecalis isolates. J. Clin. Microbiol. 45:1556-1560.
10. Lucet, J. C., D. Decre, A. Fichelle, M. L. Joly-Guillou, M. Pernet, C. Deblangy, M. J. Kosmann, and B. Regnier. 1999. Control of a prolonged outbreak of extended-spectrum beta-lactamase-producing Enterobacteriaceae in a university hospital. Clin. Infect. Dis. 29:1411-1418.
11. Meyer, E., A. Serr, C. Schneider, S. Utzolino, W. V. Kern, R. Scholz, and M. Dettenkofer. 2009. Should we screen patients for extended-spectrum beta-lactamase-producing Enterobacteriaceae in intensive care units? Infect. Control Hosp. Epidemiol. 30:103-105.
12. Paterson, D. L., and R. A. Bonomo. 2005. Extended-spectrum beta-lactamases: a clinical update. Clin. Microbiol. Rev. 18:657-686.
13. Paterson, D. L., W. C. Ko, A. Von Gottberg, J. M. Casellas, L. Mulazimoglu, K. P. Klugman, R. A. Bonomo, L. B. Rice, J. G. McCormack, and V. L. Yu. 2001. Outcome of cephalosporin treatment for serious infections due to apparently susceptible organisms producing extended-spectrum beta-lactamases: implications for the clinical microbiology laboratory. J. Clin. Microbiol. 39:2206-2212.
14. Peña, C., M. Pujol, A. Ricart, C. Ardanuy, J. Ayats, J. Linares, F. Garrigosa, J. Ariza, and F. Gudiol. 1997. Risk factors for faecal carriage of Klebsiella pneumoniae producing extended spectrum beta-lactamase (ESBL-KP) in the intensive care unit. J. Hosp. Infect. 35:9-16.
15. Pérez-Pérez, F. J., and N. D. Hanson. 2002. Detection of plasmid-mediated AmpC beta-lactamase genes in clinical isolates by using multiplex PCR. J. Clin. Microbiol. 40:2153-2162.
16. Reddy, P., M. Malczynski, A. Obias, S. Reiner, N. Jin, J. Huang, G. A. Noskin, and T. Zembower. 2007. Screening for extended-spectrum beta-lactamase-producing Enterobacteriaceae among high-risk patients and rates of subsequent bacteremia. Clin. Infect. Dis. 45:846-852.
17. Réglier-Poupet, H., T. Naas, A. Carrer, A. Cady, J. M. Adam, N. Fortineau, C. Poyart, and P. Nordmann. 2008. Performance of chromID ESBL, a chromogenic medium for detection of Enterobacteriaceae producing extended-spectrum beta-lactamases. J. Med. Microbiol. 57:310-315.
18. Soulier, A., F. Barbut, J. M. Ollivier, J. C. Petit, and A. Lienhart. 1995. Decreased transmission of Enterobacteriaceae with extended-spectrum beta-lactamases in an intensive care unit by nursing reorganization. J. Hosp. Infect. 31:89-97.